Evidence map›Paper›PMID 28507007›Full record

ReviewAdvances in nutrition (Bethesda, Md.)2017

Perspective: A Historical and Scientific Perspective of Sugar and Its Relation with Obesity and Diabetes.

Richard J Johnson, Laura G Sánchez-Lozada, Peter Andrews, Miguel A Lanaspa

Open access · bronzeAbstract readReview
In one paragraph

Review in Advances in nutrition (Bethesda, Md.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 155 citations in OpenAlex.

  1. Pooled it
  2. Ca:Mg ratio, medium-chain fatty acids, and the gut microbiome.Clinical nutrition (Edinburgh, Scotland) · 2022
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Aging · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 3 countries.

Richard J JohnsonDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO; richard.johnson@ucdenver.edu.
Laura G Sánchez-LozadaLaboratory of Renal Physiopathology, INC Ignacio Chávez, Mexico City, Mexico; and.
Peter AndrewsNatural History Museum, London, England; and.
Miguel A LanaspaDivision of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO.
Instituto Nacional de Cardiología · MXMuseum of London · GBUniversity of Colorado Denver · USUniversity of Colorado Hospital · US

Funding

PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Wendy M Kohrt · 1995 to 2026
$32.6M
Targeting fructokinase, endogenous fructose production and purine degradation for the prevention and treatment of hereditary fructose intoleranceR01DK108859 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Miguel Angel Lanaspa Garcia · 2016 to 2026
$2.4M
NIDDK NIH HHS R01 DK108859
6 · The paper itself

Abstract

Fructose-containing added sugars, such as sucrose and high-fructose corn syrup, have been experimentally, epidemiologically, and clinically shown to be involved in the current epidemics of obesity and diabetes. Here we track this history of intake of sugar as it relates to these epidemics. Key experimental studies that have identified mechanisms by which fructose causes obesity and diabetes are reviewed, as well as the evidence that the uricase mutation that occurred in the mid-Miocene in ancestral humans acted as a "thrifty gene" that increases our susceptibility for fructose-associated obesity today. We briefly review recent evidence that obesity can also be induced by nondietary sources of fructose, such as from the metabolism of glucose (from high-glycemic carbohydrates) through the polyol pathway. These studies suggest that fructose-induced obesity is driven by engagement of a "fat switch" and provide novel insights into new approaches for the prevention and treatment of these important diseases.

Indexed as

Feeding BehaviorDiabetes MellitusDietDietary SugarsFlavoring AgentsFructoseGlucoseHumansObesitySucroseUrate OxidaseDietary SugarsFlavoring AgentsFructoseGlucoseSucroseUrate Oxidaseadded sugardiabetesfructosemetabolic syndromeobesitysucrosethrifty geneuric acid

Identifiers

PMID28507007
PMCPMC5421126
OpenAlexW2614870552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.